Sphingosine is a biologically active derivative of sphingomyelin. It affects diverse cellular functions and its mechanism(s) of action is poorly defined. Tumor necrosis factor o~ (TNFol) has recently been shown to rapidly induce sphingomyelin turnover, implicating this metabolic pathway in TNFo~ signal transduction. Because TNFot is known to induce prostaglandin E2 (PGE2) production in human fibroblasts, we tested the effect of sphingosine on TNFcc-induced PGE2 production. We found that sphingosine enhanced TNFot-induced PGE2 production by as much as 18-fold over TNFot alone. Sphingosine appeared to stimulate TNFot-induced PGE2 production independent of TNFc~-mediated interleukin 1 (IL-1) production, because anti-IL-1 antibodies and IL-1 receptor antagonist protein (IRAP) did not inhibit TNFc*-induced PGE2 production or the stimulatory effect of sphingosine. TNFot stimulated PGE2 production to the same degree in normal and protein kinase C (PKC) downregulated cells in the presence and absence of sphingosine, indicating that neither TNFot nor sphingosine require active PKC to elicit their respective effects. The sphingosine analogues stearylamine and stearoyl-D-sphingosine had little or no effect on TNFo~-mediated PGE2 production, supporting a specific role for sphingosine in the activation process. Short-term (1 rain) exposure of cells to sphingosine dramatically increased TNFot-induced PGE2 production. A potential mechanism by which sphingosine could increase TNFo~-induced PGE2 production involves enhancement of phospholipase A2 (PLA2) and/or cyclooxygenase (Cox) activity, the rate-limiting enzymes in PGE2 production. We found that both TNFot and sphingosine alone enhanced these enzymatic activities, and that sphingosine additively increased the effect of TNFc~ on phospholipase A2 activity. It appears that sphingosine affects TNFolinduced PGE2 production via a mechanism that is independent of PKC involvement, and that sphingosine may function as an endogenous second messenger capable of modulating the responsiveness of the cell to external stimuli.
Summar~
Sphingosine is a biologically active derivative of sphingomyelin. It affects diverse cellular functions and its mechanism(s) of action is poorly defined. Tumor necrosis factor o~ (TNFol) has recently been shown to rapidly induce sphingomyelin turnover, implicating this metabolic pathway in TNFo~ signal transduction. Because TNFot is known to induce prostaglandin E2 (PGE2) production in human fibroblasts, we tested the effect of sphingosine on TNFcc-induced PGE2 production. We found that sphingosine enhanced TNFot-induced PGE2 production by as much as 18-fold over TNFot alone. Sphingosine appeared to stimulate TNFot-induced PGE2 production independent of TNFc~-mediated interleukin 1 (IL-1) production, because anti-IL-1 antibodies and IL-1 receptor antagonist protein (IRAP) did not inhibit TNFc*-induced PGE2 production or the stimulatory effect of sphingosine. TNFot stimulated PGE2 production to the same degree in normal and protein kinase C (PKC) downregulated cells in the presence and absence of sphingosine, indicating that neither TNFot nor sphingosine require active PKC to elicit their respective effects. The sphingosine analogues stearylamine and stearoyl-D-sphingosine had little or no effect on TNFo~-mediated PGE2 production, supporting a specific role for sphingosine in the activation process. Short-term (1 rain) exposure of cells to sphingosine dramatically increased TNFot-induced PGE2 production. A potential mechanism by which sphingosine could increase TNFo~-induced PGE2 production involves enhancement of phospholipase A2 (PLA2) and/or cyclooxygenase (Cox) activity, the rate-limiting enzymes in PGE2 production. We found that both TNFot and sphingosine alone enhanced these enzymatic activities, and that sphingosine additively increased the effect of TNFc~ on phospholipase A2 activity. It appears that sphingosine affects TNFolinduced PGE2 production via a mechanism that is independent of PKC involvement, and that sphingosine may function as an endogenous second messenger capable of modulating the responsiveness of the cell to external stimuli.
S
Phingosine, a metabolite of sphingomyelin turnover (1), can elicit a variety of cellular responses including inhibition of growth factor action (2, 3) , modulation of receptor function (4) (5) (6) , inhibition of platelet and neutrophil function (7, 8) and calmodulin dependent enzymes (9) , antagonism of phorbol ester induced responses (10) (11) (12) , and promotion of antitumor activity (1, 13) . Many of the affects of sphingosine appear to be a direct consequence of the inhibition of protein kinase C (PKC) 1 activity (7, 8, 10, 11) , a key regulatory enzyme involved in signal transduction in a variety of physiological processes (14, 15) . Although the full range of 1 Abbreviations used in this paper: Cox, cyclooxygenase; IILAE IL-1 receptor antagonist protein; PGE2, prostaglandin Ez; PKC, protein kinase C; PLAz, phospholipase A2. biochemical targets for sphingosine has yet to be identified, several PKC-independent mechanisms for sphingosine action have been recognized (16) (17) (18) . The diverse effects of sphingosine suggest that it may act as an endogenous modulator of cell function, a second messenger molecule, generated as a result of agonist-stimulated sphingolipid turnover (1). However, the mechanism(s) of sphingosine action and those signal transduction pathways that it modulates are not well defined.
TNFot is a pluripotent cytokine secreted by macrophages in response to a variety of inflammatory agents (19) . It has a broad range of in vivo activities as demonstrated by its ability to affect the growth, differentiation, and function of virtually every cell type investigated (20, 21) . Cellular responses to TNFc~ are triggered by interaction of TNFot with highaffinity cell surface receptors (22, 23) . Although sensitivity to TNFot can be modulated by regulation of receptor expres-sion, TNFc~ responsiveness appears to be largely determined at the post-receptor level. Several lines of evidence suggest the participation of protein kinases in TNFc~ signal transduction (24, 25) , and other findings support protein kinaseindependent mechanisms (26, 27) . Recently, TNFol has been shown to stimulate sphingomyelin metabolism, suggesting that this pathway may be an important signaling mechanism mediating some of the many actions of TNFot (28) .
IL-1 and TNFol are known to elicit similar responses in a variety of cell types, including stimulation of prostaglandin E2 (PGE2) production (29, 30) . Both cytokines are elaborated by mononudear cells in response to the same stimuli. They have similar functional profiles, molecular weights, and ionic characteristics (31) (32) (33) (34) , and further, TNFol can itself induce the production of IL-1 (35) . Thus, specific responses of fibroblasts to these cytokines are sometimes difficult to differentiate. We show here that sphingosine stimulates TNFo~-mediated PGE2 production via a PKC-independent pathway, at least in part, by stimulating phospholipase A2 (PLA2) activity. TNFc~-mediated Ibl production does not appear to be involved in the process. Our observation that very short exposure of cells to sphingosine is sufficient to maximally stimulate TNFol-mediated PGE2 production, together with the previous observation that TNF-o~ rapidly induces the metabolism of sphingomyelin, is consistent with the concept that sphingolipid metabolites may play an important role as endogenous second messengers in regulating the ability of cells to respond to TNFo~ and, most likely, to other cytokines. Fibroblasts Cell Lines and Culture. Six different human foreskin fibroblast lines were employed in these studies. Human foreskin fibroblasts were obtained and cultured as previously described (18) . Where indicated ceils were treated with growth factors, anti-Iblce and anti-IblB mAbs (10 and 100 #g/m1, respectively), IRAP (1 ng/ml), PMA (100 nM final in DMSO), or aliphatic amines (10 /~M), along with the appropriate vehicle controls. Sphingosine was always added as a complex with BSA, which was prepared by incubating equimolar amounts of BSA and sphingosine in Tris buffer (pH 7.4) for 1 h at 37~ Incubations typically lasted 24 h after which time the media were collected and assayed for PGE2 by ILIA. The effects of sphingosine and TNFce on cell viability were assessed by trypan blue exclusion. At 10/~M sphingosine and 1 ng/ ml TNFc~, neither cell morphology nor viability was affected during the course of the experiments described.
Materials and Methods

Cytokine Preparations and
PGE2 RM. This assay is based upon the competition of cold (sample PGE2) with labeled PGE2 for anti-PGE2-antibody binding sites as previously described (18) . The culture media were harvested from cells treated as indicated, and a 10-/~1 aliquot was added to ILIA assay buffer (0.1 mM phosphate buffer, pH 7.4, containing 0.9% sodium chloride, 0.1% sodium azide, and 0.1% gelatin). The sample was then mixed with the appropriate amount of labeled tracer and reconstituted antiserum. The mixture was allowed to equilibrate at room temperature for I h and then incubated overnight at 4~ Assay tubes were then placed in an ice bath, and I ml of a cold charcoal-dextran suspension was added. After a 15-rain incubation, the tubes were centrifuged at 2,200 g for 10 rain at 4~ the supernatants were decanted into scintillation vials and counted using liquid scintillation. Percent binding was compared against a standard curve, and the amount of PGE2 in the sample was calculated.
PKC Downregulation. Confluent fibroblast cultures were pretreated with 1/~M PMA for 24 h at 37~ After this treatment, the ceils were washed three times with Eagle's minimal essential medium (EMEM), and 0.5 ml fresh EMEM containing 1% FCS was added. The cells were then treated as indicated and PGEz was measured as described above.
PLA2 Assay. The assay used to measure PLA2 activity in cell extracts is a modification of a procedure previously described by Ballou, et al. (37) (38) (39) . Briefly, confluent fibroblast monolayers from six-well plates were washed several times with 2 ml of 100 mM Tris, pH 7.0. The cells were scraped from the plate in 120/~1 of the same buffer, sonicated for 15 s, and centrifuged at 15,000 g for 15 min. The pellet was discarded and the supernatant fraction kept on ice until assayed for PLA2 activity. Each assay contained 40 /~1 of the supernatant fraction ('~50 #g of protein), 1-palmitoyl-2-[1-14C]arachidonylphosphatidylcholine (50,000 cpm in 5/zl DMSO), and 1 mM CaCh. The assay was initiated by adding 10/~1 of a reaction mixture such that the final concentration of each component was as described above. Tubes were mixed by vortex and incubated in a 37~ water bath for 30 min. The reaction was stopped by the addition of 50/~1 of ethanol containing 2% acetic acid. Each tube was mixed by vortex and 50/zl was applied to a silica gel G TLC plate and developed in ethyl acetate/acetic acid (99:1). As indicated for certain experiments, cells were pretreated with TNFc~ and/or sphingosine for 18 h before preparation of the extract.
Cox Assay. The procedure for obtaining the cell extract was the same as for the PLA2 assay. Each Cox assay contained 40 #1 of the cell extract and 1/~M epinephrine/1 mM phenol in 100 mM Tris (pH 8.5). The reaction was initiated by adding 10 #1 1 mM arachidonic acid in ethanol to each tube. The reaction was allowed to proceed for 15 rain at 37~ and stopped by the addition of 10 #1 25 mM FeC12-4HzO. Then, the samples were stored at -20~ until PGE2 was measured by RIA as described above.
Statistical Analysis. Student's t test was used for all statistical analyses.
Results
Sphingosine Potentiates TNFol-induced PGE2 Production in Human Fibroblasts. In a series of experiments we evaluated the effect of TNFce and sphingosine on PGE2 production in human fibroblasts. In six cell lines tested, we consistently observed a dramatic increase in the amount of PGE2 produced in response to TNFce if sphingosine was also present. Fig.  1 shows that at 10/~M sphingosine, approximately 18-fold more PGE2 was produced in response to 1 ng/ml TNFce than in the absence of sphingosine. Sphingosine alone had comparatively little effect on PGE2 production at any con- Figure 1 . Sphingosine potentiates TNFr~-induced PGE2 production. Confluent human foreskin fibroblasts were treated with TNFc~ (1 ng/ml) and the indicated concentrations of sphingosine. PGE2 was measured by ILIA as described in Materials and Methods. The results are expressed as ng of PGE2 produced per 100/~1. Similar results were obtained in two additional experiments. Standard deviations between duplicate assays for each experimental treatment were less than 5%. centration tested. TNFc~-mediated PGE2 production increased as a function of sphingosine concentration. However, concentrations of sphingosine over 25/zM were cytotoxic, as previously reported (18) . Although we observed some degree of quantitative variability with respect to PGE2 production among the cell lines examined, the combination of TNFol and sphingosine invariably resulted in a synergistic increase of PGE2 production. In a series of six separate experiments each using a different fibroblast cell line, we observed a sphingosine-mediated increase in TNFc~-induced PGEz production ranging from 3.5-to 17.7-fold over TNFc~ levels alone. The lowest mean increase (3.5-fold) induced by TNFol and sphingosine over TNFcr controls was statistically significant (Student's t test, p < 0.005).
IRAP and Anti-IL I Antibodies Do Not
Inhibit TNF~/Sphingosine Synergy. TNFc~ has been shown to induce Ibl synthesis by certain target cells (35) . Therefore, to rule out potential effects of II.-1 on TNFc~-mediated PGE2 production, we tested the effects of sphingosine and TNFo~ in the presence of neutralizing Ibl (c~ and B) mAbs and IRAP. We added IRAP (1 ng/ml), which blocks the action of IL-1 by binding to IL-1 receptors with about the same af~nity as II.-1 (36), anti-IL-lot (10/~g/ml), and anti-Ibll3 (100/~g/ml), an amount that totally blocked the effect of exogenously added I1.-1 (1 ng/ml) on PGE2 production (data not shown). Fig. 2 shows that when IRAP or anti-tbl antibodies are added to the incubation medium, TNF~-induced PGE2 production remains stimulated by sphingosine. Control assays containing combinations of anti-IL-1, IRAP, sphingosine, and each alone, resulted in no effect on basal PGE2 production. Thus, sphingosine and TNFo~ appear to increase PGEz production in human fibroblasts independent of IL-1 effects, although we cannot rule out the potential effects of intracellular I1-1.
The Effect of Sphingosine on PMA and TNFol-Mediated PGE2 Production After PKC Downregulation. Many effects of sphingosine (7, 8, 10, 11) and TNFc~ (24, 25) appear to be a direct consequence of PKC inhibition or activation, respectively. PMA is a potent activator of PKC (15) prolonged exposure to PMA downregulates PKC activity in human cells (40, 41) . Therefore, we compared the effects of sphingosine and TNFo~ on PGEz production in normal and PKC-deficient cells. Fig. 3 shows that TNFc~ alone stimulates PGE2 production equally in control and PKC downregulated cells. As expected, PMA stimulates PGE2 production in normal cells but not in cells with downregulated PKC activity. Interestingly, the combination of PMA and sphingosine, both of which stimulated some PGE2 alone, resulted in no PGE2 production, perhaps because of their documented opposing effects on PKC activity. Sphingosine dramatically enhanced TNFc~-induced PGE2 production in normal cells, and this effect was not significantly decreased in cells with downregnlated PKC activity, suggesting that in this case sphingosine provides a metabolic signal to the cell that enhances TNFc~-mediated PGE2 production independent of any effects that sphingosine may have on PKC activity.
Specificity of the Sphingosine Effect.
To determine the specificity of the stimulatory effect of sphingosine on TNFo~-mediated PGE2 production, we tested the ability of two sphingosine analogues, stearoyl-D-sphingosine and stearylamine, to modulate TNFc~-mediated PGE2 production. Stearoyl-D-sphingosine lacks a free amino group and stearylamine has an alkyl chain length similar to sphingosine, but lacks both hydroxyl groups. Fig. 4 shows that in comparison to the ability of sphingosine to strongly potentiate TNFc~-mediated PGE2 production, stearylamine has some stimulatory effect, and stearoyl-o-sphingosine does not show any synergy with TNFc~.
Time Course of Sphingosine-mediated Potentiation of TNFotinduced PGE2 Production. To examine the temporal relation-
ship between sphingosine treatment and its stimulatory effect on TNFc~-induced PGE2 production, we incubated cells with sphingosine for the times indicated in Fig. 5 , washed them with fresh culture media, and then treated them with TNFot (1 ng/ml) for 24 h. Fig. 5 shows that the effect of sphingosine on TNFc~-mediated PGE2 production is extremely rapid. After only a 1-min exposure to sphingosine, TNFc~-mediated PGE2 production was enhanced to 90% of maximal and to 100% after a 5-min exposure. TNFot-mediated PGE2 production decreased after 1 h preincubation with sphingosine, and longer pre-incubations resulted in progressively lower levels of PGE2, returning to basal levels after 24 h of exposure to sphingosine. These results indicate that Preincubation Time (min) Figure 5 . The effect of sphingosine pretreatment on TNFcz-mediated PGE2 production. Confluent fibroblast cultures were exposed to sphingosine (10/~M) for the times indicated. Each well was then extensively washed to remove any remaining sphingosine. Each well was then treated with TNFc~ (1 ng/ml). Control wells were treated with sphingosine or TNFot alone and with sphingosine/TNPc~ combination. After 24 h PGE2 production was measured as described in Materials and Methods. The results are expressed as nanograms of PGE2 produced per 100/~1. Each value represents the mean of triplicate assays from two separate wells _+ SD. PGE2 production was 0.4 _+ 0.14 ng/100 #1 in control wells treated with sphingosine alone, 1.4 +_ 0.28 ng/100/zl in wells treated with TNFot alone (time zero) and 5.7 + 0.14 ng/100/~1 in wells treated with sphingosine and TNFc~ at the same time.
the effects of sphingosine on TNFot-induced PGE2 production are rapidly manifested and relatively transient. The transient nature of the sphingosine effect may be due to its rapid metabolism to an inactive metabolite by the cell.
The Effect of TNFot and Sphingosine on PLA2 and Cox Activity in Human
Fibroblasts. Cytokine-induced PGE2 production in human fibroblasts is regulated by the availability of arachidonic acid, released from phospholipids by the action of PLA2, and on its conversion to PGE2 by Cox (42) .
To directly assess the effect of sphingosine and TNFc~ on PLA2 and Cox activity, we prepared an extract from sonicated fibroblasts using untreated cells and cells treated for 18 h with TNF~, sphingosine or both. Fig. 6 shows that PLA2 activity in cells pretreated with sphingosine (10 #M) and/or TNFot (1 ng/ml) is significantly higher than basal PLA2. Moreover, PLA2 activity derived from cells pretreated with both sphingosine and TNFc~ is significantly higher than in cells pretreated with TNFot alone (p < 0.05). Similarly, Cox activity is significantly higher in cells treated with sphingosine and TNFc~ when compared with the activity measured in untreated ceils (p < 0.001), but not when compared with activity in cells treated with TNFot alone.
Discussion
Sphingolipids have been implicated in modulating many diverse cellular processes, including cellular communication, transformation, proliferation, differentiation, and receptor function (1, 43, 44) . The mechanism(s) of action and the signal transduction pathways modulated by these complex lipids remain poorly understood. Although much evidence suggests that sphingosine is a potent inhibitor of PKC activity (1, 13) , other studies indicate that sphingosine has bio-4-
._ z Figure 6 . The effect of TNFc~ and sphingosine on Cox and PLA2 activities. PLA2 and Cox activities were measured as described in Materials and Methods. PGE2 production was measured by RIA. Confluent cultures of human fibroblasts were pretreated with TNF~x and/or sphingosine for 18 h before preparation of the supernatant fraction. The concentration of each addition was: TNFot, 1 ng/ml; sphingosine 10 #M. Untreated control PLA2, Cox, and PGE2 levels were normalized to 1.0, and the fold stimulation by each treatment was calculated. Each value is the mean of three experiments from two identically treated wells +_ SD.
logical effects which are, at least in part, independent of the PKC pathway (4, 5, 16, 18) . Thus, caution has been urged in the use of sphingosine as a reagent to inhibit PKC and further, the possibility that sphingosine may not be a physiological modulator of PKC activity must be considered. The findings presented here suggest that sphingosine may be involved in modulating the responsiveness of the cell to TNFo~ Sphingosine has also been implicated as a modulator of the actions of epidermal growth factor (4), ILl (18) , and most likely, other cytokines yet to be identified. Sphingomyelin turnover involves the hydrolysis of sphingomyelin to ceramide and phosphorylation by a neutral sphingomyelinase. Some have suggested that this is an important biochemical pathway in regulating a variety of cell functions (45) . It has been demonstrated recently that TNFol causes an early and reversible sphingomyelin hydrolysis in HL-60 cells accompanied by the concomitant generation of ceramide that subsequently downregnlates mRNA production for the c-myc protooncogene (28) . A variety of other biologically active sphingolipid metabolites, such as sphingosine (4, 18) and sphingosine-l-phosphate (43) are also produced during sphingomyelin turnover. Further, sphingosine may be converted to ceramide or sphingosine-l-phosphate, thus complicating determination of the specific effects of these compounds. Clearly, each of these metabolites may modulate a wide variety of cellular responses including the ability of certain inflammatory cytokines to induce PGE2 production as shown here.
The ability of TNFot to affect the growth, differentiation, and various other functions of virtually every cell type investigated, appears to be largely determined at the postreceptor level. However, little is known about the precise intracellular pathways which mediate TNFol signal transduction. The effect of TNFc~ on PKC activation is controversial but several reports suggest that PKC activation may play a major role in TNF~x signal transduction in some (24, 25, 34) , but not all target cells (26) . With respect to transcriptional control, the relationship between TNFol and the activation or repression of specific genes remains to be elucidated. In certain cell types (Jurkat and K562), TNFcx activates transcription factor NFkB via a PKC-independent pathway (27) , further indicating that TNFo~ signal transduction does not necessarily require the involvement of PKC.
The fact that TNFo~ and IL-1 share many functional characteristics (including the stimulation of PGE2 production) led us to test the effect of sphingosine on TNFo~-mediated PGE2 production in order to determine whether similar mechanisms were involved in TNFo~-and IL-l-induced PGE2 production. Recently we showed that sphingosine greatly potentiates IL-l-mediated PGE2 production in human fibroblasts independent of PKC activation (18) . In fact, the downregulation of PKC activity by prolonged exposure to PMA (40, 41) mimicked the effect of sphingosine, suggesting that active PKC may actually inhibit IL-l-mediated PGE2 production, and that the stimulatory effect of sphingosine on IL-l-mediated PGE2 production was due in part to its ability to inhibit PKC activity. Conversely, with respect to sphingosine and TNFol, the inhibition of PKC activity by prolonged exposure to PMA had no effect on TNFoe-mediated PGE2 production in the presence or absence of sphingosine. These findings clearly suggest that some factor, or factors, not involving the PKC pathway, are responsible for the potentiation of TNF-cz-mediated PGE2 production by sphingosine.
The synergistic behavior of sphingosine and TNFcx on PGE2 production appears to be independent of the potential effects of TNFo~-induced IL-1 synthesis. Anti-IIAol, and anti-Ibl~ antibodies and IR.AP did not inhibit TNFoMnduced PGE2 production or the stimulatory effect of sphingosine, yet they completely blocked the effects of exogenously-added IL-1. Together, these results support the conclusion that TNFo~ acts independently of TNFc~-mediated IL-1 production, not only because the effects of sphingosine and TNFo~ are manifested quite rapidly but because, as previously shown, the time course of IL-l-mediated PGE2 production in cells preincubated with sphingosine (18) differs significantly from that of TNF~. Whereas sphingosine exhibits a rapid, transient effect on TNFoe-induced PGE2 production, its effect on IL-1 mediated PGE2 production was less rapid, but more sustained. This difference may be because although TNFcx seems to act entirely independently of PKC, IL-1 mediated PGE2 production may be downregulated by active PKC, and the inhibition of PKC by sphingosine requires a longer period of time to achieve (18) . Clearly, sphingosine potentiates PGE2 production in response to TNFcz or IL-1. However, the mechanism of sphingosine action appears to differ depending upon the external stimulus. Thus, the effects of sphingosine on cytokine-mediated PGE2 production are complex and cannot be attributed to any single biochemical event or process.
The precise mechanism by which sphingosine potentiates TNFc~-induced PGEz production remains unclear. Previous data obtained in studies using IL-1-and sphingosine-treated fibroblasts showed that PLA2 activity derived from these cells was significantly higher than that detected in extracts obtained from cells treated with Ibl or sphingosine alone (18) . Recently, it has been reported that both TNFol and Ibl increase PLA2 mRNA levels and secretion of PLA2 from the cell (46) . We show here that TNFo~ and sphingosine significantly increase endogenous PLA2 activity over TNFot levels. While II.-1 has been shown to induce the synthesis of Cox (42), similar studies using TNFot have not been reported. The data presented here indicate that TNFot alone significantly increases Cox activity compared to control levels but sphingosine only slightly enhances the TNFot effect on Cox activity. On the basis of observations such as these, and because increased PGE2 production is likely to be dependent upon increased PLA2 and Cox activities, we hypothesize that TNFol and sphingosine synergistically stimulate PGE2 production in human fibroblasts, at least in part, by increasing arachidonic acid mobilization via TNFc~ and sphingosineenhanced PLA2 activity, providing more substrate (arachidonic acid) for conversion to PGE2 by Cox. Even slight increases in PLA2 and/or Cox activity could account for the observed increase in PGE2 production in response to TNFot and sphingosine because end product (PGE2) is allowed to accumulate over a relatively long period of time (24 h ). The finding that sphingosine dramatically potentiates TNFc~-mediated PGE2 production could be very important relative to our understanding of the pathophysiologic mechanisms that mediate a variety of inflammatory processes. The role of PGE2, and other prostanoids, in inflammation is well established and its effects are known to include the mediation of pain, vasodilation, increased vascular permeability, and alterations in immune cell functions. Because sphingosine, and perhaps other sphingolipid metabolites, can so profoundly enhance cytokine-induced PGE2 production, it is interesting to speculate that the elevated levels of PG production commonly associated with inflammatory disorders such as rheumatoid arthritis may not result from the overproduction of inflammatory cytokines by mononuclear cells, but rather, from increased sphingomyelin turnover in the target cell which can dramatically potentiate the response of the cell to otherwise normal levels of cytokine.
